Skip to main content
logo
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG:2196)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
23.82
+1.50 (6.72%)
Oct 31, 2025, 4:08 PM HKT

HKG:2196 Revenue

Shanghai Fosun Pharmaceutical (Group) had revenue of 9.88B CNY in the quarter ending September 30, 2025, a decrease of -5.46%. This brings the company's revenue in the last twelve months to 39.55B, down -4.96% year-over-year. In the year 2024, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.07B, down -0.80%.

Revenue (ttm)
39.55B CNY
Revenue Growth
-4.96%
P/S Ratio
1.85
Revenue / Employee
975.14K CNY
Employees
40,557
Market Cap
79.81B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202441.07B-332.34M-0.80%
Dec 31, 202341.40B-2.55B-5.81%
Dec 31, 202243.95B4.94B12.66%
Dec 31, 202139.01B8.70B28.72%
Dec 31, 202030.31B1.72B6.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
JD Health International71.34B
BeOne Medicines AG35.81B
Sino Biopharmaceutical33.49B
Alibaba Health Information Technology32.81B
CSPC Pharmaceutical Group28.49B
WuXi Biologics21.98B
Hansoh Pharmaceutical Group Company14.45B
Innovent Biologics12.52B
Revenue Rankings

Shanghai Fosun Pharmaceutical (Group) News

More News